# Phenytoin

## Aleviatin inj 250mg/5mL

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | IALE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Indications        | Control of status epilepticus of the tonic-clonic (grand mal) type; prevention & treatment of seizures which occur during or following neurosurgery &/or severe head injury                                                                                                                                                                                                                                                                                                                         |
| Dosing             | Continuous epileptic state: The initial dose for adults (loading dose) is 10-15 mg/kg， and slowly intravenous injection at a rate of no more than 50 mg/min. Then use a maintenance dose of 100 mg orally or intravenously every 6-8 hours. Newborns and children: After an initial dose of 15-20 mg/kg body weight intravenously， the usual therapeutic concentration (10-20 mcg/mL) is usually reached.                                                                                         |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Sinus bradycardia， heart block， Stokes-Adams syndrome.                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Nystagmus， ataxia， slurred speech， decreased coordination， mental confusion， paraesthesia， drowsiness， vertigo; severe cardiotoxic reactions & fatalities; GI disturbances， scarlatiniform or measles-like rashes; pain & inflammation at inj site; gingival hypertrophy， coarse facies， acne & hirsutism， fever & hepatitis. Rarely， haematological effects， including megaloblastic anaemia， thrombocytopenia， leucopenia， granulocytopenia， agranulocytosis & aplastic anaemia. |
| Pregnancy          | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

## Dilantin 100mg

##### 

| Title              | Content                                                                                                                                                                                                                                                                                    |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | ODIL                                                                                                                                                                                                                                                                                       |
| Indications        | 主治癲癇、三叉神經痛及其他神經痛(N000817100) Control of generalized tonic-clonic (grand mal) & complex partial (psychomotor， temporal lobe) seizures. Prevention & treatment of seizures occurring during or following neurosurgery.                                                      |
| Dosing             | Seizure， During and following neurosurgery; Treatment and Prophylaxis Oral: Adult: 100 mg BID or TID， adjusted as needed; (maximum loading dose: 1000 mg/day in 3 divided doses). Child: Initial， 5 mg/kg/day in 2-3 divided doses; maintenance， 4-8 mg/kg/day; (maximum: 300 mg/day). |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                              |
| Contraindications  | Sinus bradycardia， sino-atrial block， 2nd and 3rd degree AV block or in patients with Adams-Stokes sybdrome.                                                                                                                                                                             |
| Adverse Effects    | GI disturbances; ataxia， slurred speech; diplopia， nystagmus & mental confusion with headache， dizziness， gingival hyperplasia， hirsutism， hyperglycemia， osteomalacia.                                                                                                             |
| Pregnancy          | Compatible – maternal benefit >> embryo-fetal risk                                                                                                                                                                                                                                         |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                 |

